CN103710431A - 一种检测基因突变引物及应用 - Google Patents
一种检测基因突变引物及应用 Download PDFInfo
- Publication number
- CN103710431A CN103710431A CN201310525078.0A CN201310525078A CN103710431A CN 103710431 A CN103710431 A CN 103710431A CN 201310525078 A CN201310525078 A CN 201310525078A CN 103710431 A CN103710431 A CN 103710431A
- Authority
- CN
- China
- Prior art keywords
- primer
- detection
- transgenation
- sequence
- base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 53
- 206010064571 Gene mutation Diseases 0.000 title claims abstract description 10
- 230000003321 amplification Effects 0.000 claims abstract description 24
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 24
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 8
- 229930010555 Inosine Natural products 0.000 claims abstract description 7
- 229960003786 inosine Drugs 0.000 claims abstract description 7
- 238000007403 mPCR Methods 0.000 claims abstract description 6
- 230000008859 change Effects 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 20
- 238000000137 annealing Methods 0.000 claims description 15
- 230000004087 circulation Effects 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 6
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 5
- 102000039446 nucleic acids Human genes 0.000 claims description 5
- 150000007523 nucleic acids Chemical class 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 230000011664 signaling Effects 0.000 claims description 3
- UBORTCNDUKBEOP-UHFFFAOYSA-N L-xanthosine Natural products OC1C(O)C(CO)OC1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UHFFFAOYSA-N 0.000 abstract description 2
- UBORTCNDUKBEOP-HAVMAKPUSA-N Xanthosine Natural products O[C@@H]1[C@H](O)[C@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-HAVMAKPUSA-N 0.000 abstract description 2
- UBORTCNDUKBEOP-UUOKFMHZSA-N xanthosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UUOKFMHZSA-N 0.000 abstract description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract 2
- 230000000295 complement effect Effects 0.000 abstract 1
- 238000003752 polymerase chain reaction Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 41
- 238000013461 design Methods 0.000 description 24
- 101150111062 C gene Proteins 0.000 description 18
- 239000013612 plasmid Substances 0.000 description 18
- 238000005516 engineering process Methods 0.000 description 14
- 239000003814 drug Substances 0.000 description 8
- 238000011895 specific detection Methods 0.000 description 6
- 101150076489 B gene Proteins 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 4
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 4
- 229960001627 lamivudine Drugs 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000000171 quenching effect Effects 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 241000700721 Hepatitis B virus Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 108091028733 RNTP Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000012631 diagnostic technique Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 229960001997 adefovir Drugs 0.000 description 1
- WOZSCQDILHKSGG-UHFFFAOYSA-N adefovir depivoxil Chemical compound N1=CN=C2N(CCOCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)C=NC2=C1N WOZSCQDILHKSGG-UHFFFAOYSA-N 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007847 digital PCR Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 101150118163 h gene Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 101150068477 mlc gene Proteins 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000007862 touchdown PCR Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
材料名称 | 公司 |
Hotstart Taq polymerase | 上海生工 |
Mg2+ | 上海生工 |
PCR buffer | 上海生工 |
dNTP mix(dA、dG、dC、dT) | Promega |
名称 | 5'~3' | 修饰 |
180R | GCACTAGTAAACTGAGIIIICCATGA | dI |
180F | TGTTTCCCTCTTGTTGCTGT | N/A |
180P | CACCTGTATTCCCATCCCATCATCTT | 5FAM,3TAMRA |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310525078.0A CN103710431B (zh) | 2013-10-30 | 2013-10-30 | 一种检测基因突变的引物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310525078.0A CN103710431B (zh) | 2013-10-30 | 2013-10-30 | 一种检测基因突变的引物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103710431A true CN103710431A (zh) | 2014-04-09 |
CN103710431B CN103710431B (zh) | 2017-04-19 |
Family
ID=50403782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310525078.0A Active CN103710431B (zh) | 2013-10-30 | 2013-10-30 | 一种检测基因突变的引物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103710431B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104745461A (zh) * | 2015-04-28 | 2015-07-01 | 北京中科紫鑫科技有限责任公司 | 一种用于测序的基因芯片及其制备方法 |
CN105861678A (zh) * | 2016-04-29 | 2016-08-17 | 广州市康立明生物科技有限责任公司 | 一种用于扩增低浓度突变靶序列的引物和探针的设计方法 |
CN107904294A (zh) * | 2017-12-28 | 2018-04-13 | 广州和实生物技术有限公司 | 一种用于检测基因突变的凸环‑arms引物及其应用方法 |
WO2024082624A1 (zh) * | 2022-10-21 | 2024-04-25 | 南京普济生物医学有限公司 | 一种带有茎环结构的引物及应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130090464A1 (en) * | 2005-03-05 | 2013-04-11 | Seegene, Inc. | Process Using Dual Specificity Oligonucleotide and Dual Specificity Oligonucleotide |
-
2013
- 2013-10-30 CN CN201310525078.0A patent/CN103710431B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130090464A1 (en) * | 2005-03-05 | 2013-04-11 | Seegene, Inc. | Process Using Dual Specificity Oligonucleotide and Dual Specificity Oligonucleotide |
Non-Patent Citations (2)
Title |
---|
20070207: "Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene", 《NUCLEIC ACIDS RESEARCH》, vol. 35, no. 6, 7 February 2007 (2007-02-07), XP 055052962, DOI: doi:10.1093/nar/gkm051 * |
SHERRY XI CHEN ET AL.: "Conditionally fluorescent molecular probes for detecting single base changes in double-stranded DNA", 《NAT CHEM》, vol. 5, no. 9, 30 September 2013 (2013-09-30), pages 1713 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104745461A (zh) * | 2015-04-28 | 2015-07-01 | 北京中科紫鑫科技有限责任公司 | 一种用于测序的基因芯片及其制备方法 |
CN104745461B (zh) * | 2015-04-28 | 2016-06-08 | 北京中科紫鑫科技有限责任公司 | 一种用于测序的基因芯片及其制备方法 |
CN105861678A (zh) * | 2016-04-29 | 2016-08-17 | 广州市康立明生物科技有限责任公司 | 一种用于扩增低浓度突变靶序列的引物和探针的设计方法 |
CN105861678B (zh) * | 2016-04-29 | 2019-12-13 | 广州市康立明生物科技有限责任公司 | 一种用于扩增低浓度突变靶序列的引物和探针的设计方法 |
CN107904294A (zh) * | 2017-12-28 | 2018-04-13 | 广州和实生物技术有限公司 | 一种用于检测基因突变的凸环‑arms引物及其应用方法 |
WO2024082624A1 (zh) * | 2022-10-21 | 2024-04-25 | 南京普济生物医学有限公司 | 一种带有茎环结构的引物及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103710431B (zh) | 2017-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105164280A (zh) | 使用阻断性寡核苷酸进行dna扩增的方法 | |
CN106811533B (zh) | 一种遗传性耳聋基因检测试剂盒 | |
US20110269192A1 (en) | Loop-shaped primer used in nucleic acid amplification and the use thereof | |
CN109844137A (zh) | 用于鉴定嵌合产物的条形码化环状文库构建 | |
CN105593378B (zh) | 用于在人ezh2基因中检测突变的方法和组合物 | |
CN102925562B (zh) | 氨基糖苷类药物性耳聋易感基因检测试剂盒及方法 | |
CN103710431A (zh) | 一种检测基因突变引物及应用 | |
CN107893109A (zh) | 一种基于移除野生型序列的低丰度基因突变富集方法 | |
CN101182585B (zh) | 一种鉴别hbv基因突变类型的方法及其专用芯片与试剂盒 | |
CN108060213B (zh) | 基于探针导向的重组酶介导的等温扩增法检测snp位点用探针和试剂盒 | |
CN101348831B (zh) | 一种快速检测空肠弯曲杆菌大环内酯类耐药突变点的荧光定量pcr方法 | |
CN102286616A (zh) | 一种检测结核分枝杆菌异烟肼耐药基因突变的方法及试剂盒 | |
US20100009412A1 (en) | Novel Oligonucleotide Primers and Methods for DNA Replication | |
CN107475461A (zh) | 一种检测乙型肝炎病毒耐药性基因的引物、试剂盒和方法 | |
CN115323075A (zh) | 一种检测鸡传染性支气管炎病毒及基因分型的rt-raa引物探针组、试剂盒及其应用 | |
CN115678974A (zh) | 一种应用于荧光定量pcr的双探针方法 | |
CN104862382A (zh) | 检测酒精代谢基因的方法及套组 | |
CN109022556A (zh) | 一种dna甲基化程度的定量方法及应用 | |
CN101250581B (zh) | 一种检测乙型肝炎病毒p基因ymdd变异的置换扩增法 | |
CN107043808A (zh) | Ugt1a1基因多态性检测引物肽核酸及其试剂盒 | |
KR20200129600A (ko) | 헬리코박터 파일로리(Helicobacter pylori) 유전형 판별용 PNA 프로브 및 이를 이용한 헬리코박터 파일로리 유전형 판별방법 | |
Steinlein et al. | Reverse dot blot assay (insertion site typing) for precise detection of sites of IS 6110 insertion in the Mycobacterium tuberculosis genome | |
CN114277102B (zh) | 用于检测人体液中的HLA-B27基因的RAA引物、CrRNA、试剂盒及检测方法 | |
CN114008217B (zh) | 检测核酸的组合、方法及试剂盒 | |
CN117230219A (zh) | 一种检测结核分枝杆菌异烟肼耐药基因突变的核酸组合物、试剂盒及检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171204 Address after: Tianning District 213000 Jiangsu province Changzhou Lihua village three Room 302 unit 48 C Patentee after: Wang Yongzhong Address before: 213001 Jiangsu province Changzhou Lanling Road No. 300 Patentee before: CHANGZHOU NO.3 PEOPLE'S HOSPITAL |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210310 Address after: 213000 Changyang Road, West Taihu Science and Technology Industrial Park, Wujin District, Changzhou City, Jiangsu Province Patentee after: Changzhou Keer Life Technology Co.,Ltd. Address before: 213000 Room 302, unit C, building 48, lihuasan village, Tianning District, Changzhou City, Jiangsu Province Patentee before: Wang Yongzhong |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231214 Address after: Room 302-1, Building 17, No. 8 Jinfeng Road, Suzhou High tech Zone, Suzhou City, Jiangsu Province, 215163 Patentee after: Suzhou Ke'er Life Technology Co.,Ltd. Address before: 213000 Changyang Road, West Taihu Science and Technology Industrial Park, Wujin District, Changzhou City, Jiangsu Province Patentee before: Changzhou Keer Life Technology Co.,Ltd. |